GlassScriptNo Marketed Product Name
Payments companies reported to CMS as associated with No Marketed Product Name. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with No Marketed Product Name, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with No Marketed Product Name
These are the largest totals companies reported as associated with No Marketed Product Name. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Charles Taunt | Lansing, MI | Adult Reconstructive Orthopaedic Surgery | $110.67 |
| Joseph Gorman | Philadelphia, PA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $107.31 |
| Juan Samayoa Escobar | Minneapolis, MN | Pediatric Cardiology | $72.68 |
| Gurumurthy Hiremath Mallikarjun | Minneapolis, MN | Pediatrics | $72.68 |
| John Bass | Minneapolis, MN | Pediatric Cardiology | $62.35 |
| David Bloom | Salt Lake City, UT | Pediatric Cardiology | $45.41 |
| Michael Slack | Baltimore, MD | Pediatric Cardiology | $45.41 |
| William Moskowitz | Richmond, VA | Pediatric Cardiology | $42.56 |
| Makram Ebeid | Jackson, MS | Pediatric Cardiology | $42.56 |
| William Mihalko | Charlottesville, VA | Orthopaedic Surgery | $38.34 |
Prescribed No Marketed Product Name?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.